VBIV logo

VBI Vaccines (VBIV) Current Liabilities

Annual Current Liabilities

$75.74 M
+$38.79 M+105.01%

December 31, 2023

Summary

Performance

1-Year Change

+105.01%

3-Year Change

+336.57%

5-Year Change

+223.98%

15-Year Change

+472.2%

VBIV Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$75.74 M
VBIV annual total current liabilities is currently at an all-time high

3-Year Low

$32.59 M
VBIV annual total current liabilities is currently +132.42% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VBIV previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
VBIV next annual earnings announcement has not yet been scheduled

OtherVBIVbalance sheetmetrics:

Annual Total Liabilities

$79.42 M
VBIV annual total liabilities is $79.42 million

Annual Total Long Term Liabilities

$3.69 M
VBIV annual total long term liabilities is $3.69 million

Annual Total Assets

$86.95 M
VBIV annual total assets is $86.95 million

Annual Current Assets

$36.23 M
VBIV annual total current assets is $36.23 million

Quarterly Current Liabilities

$77.59 M
+$1.86 M+2.45%

March 31, 2024

Summary

Performance

3-Month Change

+2.45%

1-Year Change

+180.39%

3-Year Change

+110.04%

5-Year Change

+110.04%

VBIV Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$77.59 M
VBIV quarterly total current liabilities is currently at an all-time high

3-Year Low

$27.67 M
VBIV quarterly total current liabilities is currently +180.39% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
VBIV previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
VBIV next earnings announcement has not yet been scheduled

OtherVBIVbalance sheetmetrics:

Quarterly Total Liabilities

$80.91 M
VBIV quarterly total liabilities is $80.91 million

Quarterly Long Term Liabilities

$3.32 M
VBIV quarterly total long term liabilities is $3.32 million

Quarterly Total Assets

$75.44 M
VBIV quarterly total assets is $75.44 million

Quarterly Current Assets

$26.36 M
VBIV quarterly total current assets is $26.36 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$75.74 M
VBIV annual total current liabilities is $75.74 million

Annual Accounts Payable

$6.43 M
VBIV annual accounts payable is $6.43 million

Annual Short Term Debt

$51.74 M
VBIV annual short term debt is $51.74 million

VBIV Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+105.0%+180.4%
3 y3 years+336.6%+110.0%
5 y5 years+224.0%+110.0%

VBIV Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-57.0%at high-64.3%
5 y5-yearat high-77.1%at high-82.0%
alltimeall timeat high-100.0%at high-100.0%

VBI Vaccines Current Liabilities History

DateAnnualQuarterly
Mar 2024
-
$77.59 M(+2.5%)
Dec 2023
$75.74 M(+105.0%)
$75.74 M(-1.9%)
Sep 2023
-
$77.19 M(+178.9%)
Jun 2023
-
$27.67 M(-6.4%)
Mar 2023
-
$29.57 M(-19.9%)
Dec 2022
$36.94 M(+13.4%)
$36.94 M(+6.5%)
Sep 2022
-
$34.68 M(-14.4%)
Jun 2022
-
$40.53 M(+19.2%)
Mar 2022
-
$33.99 M(+4.3%)
Dec 2021
$32.59 M(+87.8%)
$32.59 M(-1.1%)
Sep 2021
-
$32.95 M(+26.4%)
Jun 2021
-
$26.07 M(+9.4%)
Mar 2021
-
$23.82 M(+37.3%)
Dec 2020
$17.35 M(-41.7%)
$17.35 M(+24.4%)
Sep 2020
-
$13.95 M(-8.1%)
Jun 2020
-
$15.18 M(-47.9%)
Mar 2020
-
$29.13 M(-2.1%)
Dec 2019
$29.76 M(+27.3%)
$29.76 M(-2.0%)
Sep 2019
-
$30.36 M(-12.2%)
Jun 2019
-
$34.58 M(+50.4%)
Mar 2019
-
$22.99 M(-1.6%)
Dec 2018
$23.38 M(+76.6%)
$23.38 M(+24.6%)
Sep 2018
-
$18.77 M(+14.9%)
Jun 2018
-
$16.33 M(+2.0%)
Mar 2018
-
$16.01 M(+21.0%)
Dec 2017
$13.24 M(+73.8%)
$13.24 M(+5.2%)
Sep 2017
-
$12.58 M(+33.7%)
Jun 2017
-
$9.41 M(+20.9%)
Mar 2017
-
$7.78 M(+2.2%)
Dec 2016
$7.61 M(+160.0%)
$7.61 M(-14.7%)
Sep 2016
-
$8.93 M(+30.2%)
Jun 2016
-
$6.86 M(+118.8%)
Mar 2016
-
$3.14 M(+7.1%)
Dec 2015
$2.93 M(+959.3%)
$2.93 M(+2.3%)
Sep 2015
-
$2.86 M(+210.9%)
Jun 2015
-
$921.00 K(+233.1%)
Mar 2015
-
$276.50 K(+25.2%)
Mar 2015
$276.50 K(+11.1%)
-
Dec 2014
-
$220.90 K(+30.6%)
Sep 2014
-
$169.20 K(-25.5%)
Jun 2014
-
$227.10 K(-8.7%)
Mar 2014
$248.80 K(+3.7%)
$248.80 K(+55.2%)
Dec 2013
-
$160.30 K(+14.8%)
Sep 2013
-
$139.60 K(-1.4%)
Jun 2013
-
$141.60 K(-41.0%)
Mar 2013
$240.00 K(-66.2%)
$240.00 K(-23.7%)
Dec 2012
-
$314.70 K(+8.1%)
Sep 2012
-
$291.10 K(-6.2%)
Jun 2012
-
$310.20 K(-56.3%)
Mar 2012
$710.00 K
$710.00 K(+47.1%)
DateAnnualQuarterly
Dec 2011
-
$482.80 K(-54.4%)
Sep 2011
-
$1.06 M(+57.9%)
Jun 2011
-
$670.70 K(-24.3%)
Mar 2011
$886.50 K(+333.1%)
$886.50 K(-73.3%)
Dec 2010
-
$3.32 M(+48.8%)
Sep 2010
-
$2.23 M(+924.4%)
Jun 2010
-
$218.00 K(+6.5%)
Mar 2010
$204.70 K(+27.3%)
$204.70 K(-7.4%)
Dec 2009
-
$221.00 K(+53.8%)
Sep 2009
-
$143.70 K(-33.3%)
Jun 2009
-
$215.40 K(+34.0%)
Mar 2009
$160.80 K(-17.0%)
$160.80 K(+30.1%)
Dec 2008
-
$123.60 K(-1.5%)
Sep 2008
-
$125.50 K(-27.9%)
Jun 2008
-
$174.00 K(-10.2%)
Mar 2008
$193.70 K(+36.7%)
$193.70 K(-13.6%)
Dec 2007
-
$224.20 K(-1.0%)
Sep 2007
-
$226.40 K(+37.7%)
Jun 2007
-
$164.40 K(+16.0%)
Mar 2007
$141.70 K(-42.2%)
$141.70 K(-59.1%)
Dec 2006
-
$346.30 K(+46.6%)
Sep 2006
-
$236.20 K(-13.9%)
Jun 2006
-
$274.20 K(+11.8%)
Mar 2006
$245.30 K(-0.2%)
$245.30 K(-25.5%)
Dec 2005
-
$329.30 K(+10.3%)
Sep 2005
-
$298.50 K(+12.7%)
Jun 2005
-
$264.80 K(+7.7%)
Mar 2005
$245.90 K(+349.5%)
$245.90 K(+360.5%)
Dec 2004
-
$53.40 K(-11.6%)
Sep 2004
-
$60.40 K(+3.8%)
Jun 2004
-
$58.20 K(+6.4%)
Mar 2004
$54.70 K(-71.9%)
$54.70 K(-73.6%)
Dec 2003
-
$206.90 K(+5.3%)
Sep 2003
-
$196.50 K(-3.8%)
Jun 2003
-
$204.20 K(+4.9%)
Mar 2003
$194.70 K(+46.2%)
$194.70 K(+8.8%)
Dec 2002
-
$178.90 K(+1054.2%)
Sep 2002
-
$15.50 K(-89.7%)
Jun 2002
-
$150.30 K(+12.8%)
Mar 2002
$133.20 K(+188.9%)
$133.20 K(+44.5%)
Dec 2001
-
$92.20 K(+15.4%)
Sep 2001
-
$79.90 K(+37.0%)
Jun 2001
-
$58.30 K(+26.5%)
Mar 2001
$46.10 K(-77.7%)
$46.10 K(+12.7%)
Dec 2000
-
$40.90 K(-4.9%)
Sep 2000
-
$43.00 K(-79.2%)
Mar 2000
$206.50 K(+55.8%)
$206.50 K(+55.8%)
Mar 1999
$132.50 K(+88.2%)
$132.50 K(+88.2%)
Mar 1998
$70.40 K(>+9900.0%)
$70.40 K(+0.7%)
Dec 1997
-
$69.90 K
Mar 1997
$0.00
-

FAQ

  • What is VBI Vaccines annual total current liabilities?
  • What is the all time high annual current liabilities for VBI Vaccines?
  • What is VBI Vaccines annual current liabilities year-on-year change?
  • What is VBI Vaccines quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for VBI Vaccines?
  • What is VBI Vaccines quarterly current liabilities year-on-year change?

What is VBI Vaccines annual total current liabilities?

The current annual current liabilities of VBIV is $75.74 M

What is the all time high annual current liabilities for VBI Vaccines?

VBI Vaccines all-time high annual total current liabilities is $75.74 M

What is VBI Vaccines annual current liabilities year-on-year change?

Over the past year, VBIV annual total current liabilities has changed by +$38.79 M (+105.01%)

What is VBI Vaccines quarterly total current liabilities?

The current quarterly current liabilities of VBIV is $77.59 M

What is the all time high quarterly current liabilities for VBI Vaccines?

VBI Vaccines all-time high quarterly total current liabilities is $77.59 M

What is VBI Vaccines quarterly current liabilities year-on-year change?

Over the past year, VBIV quarterly total current liabilities has changed by +$49.92 M (+180.39%)